The global rosehip market is projected to experience a compound annual growth rate (CAGR) of 5.6% from 2024 to 2034, with revenues increasing from US$ 282.6 million in 2024 to US$ 486.7 million by the end of the forecast period. Rosehips, the fruit of the Rosa canina, a wild rose species from the Rosaceae family, are widely used in herbal medicine. This plant thrives across various...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian